USE OF HDAC INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL CANCERS - Patent 2142190

(19)

(11)

EP 2 142 190 A1

(12)

(43)	Date of publication:
	13.01.2010 Bulletin 2010/02

(21)	Application number: 08747442.5

(22)	Date of filing: 02.05.2008

(51)

International Patent Classification (IPC):

A61K 31/4045^(2006.01)

A61K 35/00^(2006.01)

(86)	International application number:
	PCT/US2008/062341

(87)	International publication number:
	WO 2008/137630 (13.11.2008 Gazette 2008/46)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30)

Priority:

04.05.2007 US 915996 P

(71)	Applicant: Novartis AG
	4056 Basel (CH)

(72)	Inventor:
	ATADJA, Peter, Wisdom Acton, MA 01720 (US)

(74)	Representative: Roth, Peter Richard
	Novartis AG Corporate Intellectual Property 4002 Basel 4002 Basel (CH)

(54)	USE OF HDAC INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL CANCERS